UPDATE: Morgan Stanley Reiterates Equal-Weight Rating, Removes PT on LifePoint Hospitals Following 3Q14 Report

In a report published Monday, Morgan Stanley analyst Andrew Schenker reiterated an Equal-Weight rating on

, but removed the $76.00 price target. In the report, Morgan Stanley noted, “Our updated 2015 EBITDA est. of $700M reflects improving utilization trends and reform. The quarter saw positive underlying reform metrics as LPNT saw greater SS self-pay declines vs. 2Q. Separately, volumes in the quarter improved with SS equivalent admissions up 4.5% Y/Y.” LifePoint Hospitals closed on Friday at $70.73.